Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravitreal Bevacizumab for Severe Non-proliferative Diabetic Retinopathy
NCT04511715Phase 3Unknown
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Sep 2020
- Primary completion
- Jan 2021
- Modality
- Monoclonal Antibodies
01
Overview
A Phase 3 trial of bevacizumab, sponsored by Shahid Beheshti University of Medical Sciences. Status: unknown.
02
Drugs
bevacizumab
Beyond the preview
Go deeper on NCT04511715.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04511715.